Ocemida Nexis (6000-PRO) Flagship device delivers laboratory-grade hydrogen concentrations for performance-focused consumers and researchers alike Ocemida, a Canadian innovator in molecular hydrogen technology, today announced that its flagship Ocemida Nexis has achieved the highest hydrogen concentration recorded by H2Hubb for … Continue reading →
SALT LAKE CITY, UT – Feb 2, 2026 – Waveguard, a technology company rooted in German engineering and independent scientific research, has been recognized as a leading provider of consumer electromagnetic field (EMF) protection devices designed to help individuals and families … Continue reading →
UK job listings on Data Index show AI roles moving from R&D to product and operations, with emphasis on integration, testing and monitoring. Review of job listing language indexed on Data Index suggests UK employers are shifting AI hiring toward … Continue reading →
DelveInsight’s “IgG4-Related Disease Market Insights, Epidemiology, and Market Forecast- 2034” report delivers an in-depth understanding of the IgG4-Related Disease, historical and forecasted epidemiology and the IgG4-Related Disease market trends in the United States, EU4 (Germany, France, Italy, and Spain) and … Continue reading →
DelveInsight’s “Diabetic Kidney Disease Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Diabetic Kidney Disease, historical and forecasted epidemiology and the Diabetic Kidney Disease market trends in the United States, EU4 (Germany, France, … Continue reading →
DelveInsight’s “Warm Autoimmune Hemolytic Anemia Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Warm Autoimmune Hemolytic Anemia, historical and forecasted epidemiology and the Warm Autoimmune Hemolytic Anemia market trends in the United States, … Continue reading →
“Caregiver sleep disruption isn’t just a phase or a minor inconvenience,” said Shimin Ooi, CEO of Sleep Reset. “The combination of frequent awakenings, stress, and irregular schedules puts caregivers, especially mothers, at elevated risk for serious physical and mental health … Continue reading →
DelveInsight’s, “Follicular Lymphoma Pipeline Insight, 2025” report provides comprehensive insights about 45+ companies and 50+ pipeline drugs in Follicular Lymphoma pipeline landscape. It covers the Follicular Lymphoma pipeline drug profiles, including clinical and nonclinical stage products. It also covers the … Continue reading →
DelveInsight’s “Fabry Disease Pipeline Insight 2025” report provides comprehensive insights about 18+ companies and 18+ pipeline drugs in the Fabry Disease pipeline landscape. It covers the Fabry Disease pipeline drug profiles, including clinical and nonclinical stage products. It also covers … Continue reading →
DelveInsight’s “Paroxysmal Nocturnal Hemoglobinuria Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of the Paroxysmal Nocturnal Hemoglobinuria, historical and forecasted epidemiology and the Paroxysmal Nocturnal Hemoglobinuria market trends in the United States, EU4 (Germany, France, … Continue reading →